Perbedaan Cipta Sarana Medika Tbk. dan Japfa Comfeed Indonesia Tbk.: Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt), sedangkan Japfa Comfeed Indonesia Tbk. diperdagangkan di Rp2.030 (kapitalisasi pasar 23,69 T, volume 24 jam 13,03 jt). Perbedaan utamanya: Japfa Comfeed Indonesia Tbk. jauh lebih besar — sekitar 149,8× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Japfa Comfeed Indonesia Tbk. lebih aktif diperdagangkan (13,03 jt vs 8,21 jt). Mana yang lebih baik tergantung tujuan investasimu.
| DKHH | JPFA | |
|---|---|---|
Kapitalisasi Pasar | 158,12 M | 23,69 T |
Volume | 8,21 jt | 13,03 jt |
Lot | 82,15 rb | 130,26 rb |
Perputaran | 515,2 jt | 26,31 M |
Harga Rata-rata | 62,72 | 2.019,74 |
Nilai Transaksi | 515,2 jt | 26,31 M |
Harga Ekuilibrium Indikatif | 63 | 2.030 |
Volume Ekuilibrium Indikatif | 1,33 rb | 8,34 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Selengkapnya di halaman JPFA →